Jump to content

Chulalongkorn combats cancer in lab animals with plant-based antibody


snoop1130

Recommended Posts

im_190666_563204.jpg

 

For the first time in Thailand, lecturers at Chulalongkorn University’s Faculty of Pharmaceutical Sciences have successfully developed antibody from tobacco plants with inhibitory effects on the growth of cancer cells in laboratory animals. This signals hope for access to effective cancer medication and treatment at a lower cost.

 

From world-class success in producing a COVID-19 vaccine from tobacco plants, today researchers from Baiya Phytopharm Co., Ltd., a Thai company under Chulalongkorn University, have reached another milestone in the research and development of antibody drugs from tobacco plants, which have been found to reduce the size and inhibit the growth of cancer cells in laboratory animals.

 

“Our research team has developed the technology and system to produce plant proteins to make antibody drugs, with the hope to help reduce the cost of drug production so that cancer patients in the country can access drugs more easily and widely,” Assoc. Prof. Dr. Waranyoo Phoolcharoen of Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, spoke of the objectives of conducting biopharmaceutical research for cancer immunotherapy treatment.

 

The potential of this research has recently been recognized by a 2023 research award from the National Research Council of Thailand (NRCT).

 

Origin of the production of antibody drugs from tobacco plants

 

Assoc. Prof. Dr. Waranyoo explains immunotherapy for cancer: “Cancer is caused by cancer cells binding to cells in the immune system and blocking the functioning of cells in the body. The commonly known chemotherapy uses drugs to kill cancer cells in the body. For immunotherapy or cell therapy, however, the aim is not to destroy cancer cells, but stimulate the immune cells in the patient’s immune system to strengthen, thus blocking cancer cells from binding to cells in the immune system and allowing the system to handle cancer cells by itself.”

 

By Thaiger

Caption: Photo courtesy of Chulalongkorn

 

Full Story: https://thethaiger.com/news/national/chulalongkorn-combats-cancer-in-lab-animals-with-plant-based-antibody

 

Thaiger

-- © Copyright Thaiger 2023-07-31

 

- Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

  • Like 2
Link to comment
Share on other sites

I am convinced there are already multiple cures for cancer. Trillions have been spent on research, for decades. There is simply too much at stake. Entire Oncology departments in hospitals, Big Pharma, the crooked FDA, the entire medical industry, insurance, etc. I don't think they want a cure. We certainly do. But them? 

  • Love It 1
Link to comment
Share on other sites

4 hours ago, spidermike007 said:

I am convinced there are already multiple cures for cancer. Trillions have been spent on research, for decades. There is simply too much at stake. Entire Oncology departments in hospitals, Big Pharma, the crooked FDA, the entire medical industry, insurance, etc. I don't think they want a cure. We certainly do. But them? 

fully agreed

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...